NBIX Insider Trading Activity and SEC Form 4 Filings
NBIX insider trading summary
Over the past 12 months, insiders at Neurocrine Biosciences Inc (NBIX) reported 47 sales worth $74.6M by 14 insiders and no open-market purchases on SEC Form 4. Net insider selling was $74.6M.
Latest NBIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | George J Morrow | Director | Sell | $252K (1,500 @ $167.72) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $150K (908 @ $165.71) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $244K (1,466 @ $166.77) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $219K (1,300 @ $168.53) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $98K (600 @ $163.71) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $202K (1,226 @ $164.74) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $16K (100 @ $158.18) |
| Nov 3, 2026 | George J Morrow | Director | Sell | $16K (100 @ $162.05) |
| Nov 2, 2026 | George J Morrow | Director | Sell | $275K (1,900 @ $144.98) |
| Nov 2, 2026 | George J Morrow | Director | Sell | $627K (4,300 @ $145.86) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.